Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DAPK1 intronic transcript 1 (DAPK1-IT1) is a long non-coding RNA transcribed from the intronic regions of the DAPK1 (Death Associated Protein Kinase 1) gene. Unlike protein-coding splice variants of DAPK1, DAPK1-IT1 functions at the RNA level, regulating DAPK1 mRNA stability and, as a competing endogenous RNA, modulating the availability of specific microRNAs such as miR-590-3p. Through these actions, DAPK1-IT1 can repress DAPK1 protein levels and modify cell migration and invasion, particularly in cancer cells, and also influence inflammatory processes relevant to atherogenesis. It does not function as a therapeutic target in the traditional sense (e.g., receptor, enzyme) but represents a regulatory node that could have biomarker or investigational therapeutic significance in cancer, cardiovascular, and inflammatory diseases[2][4][5].
Acts as a competing endogenous RNA (ceRNA) by sponging microRNAs such as miR-590-3p; also modulates DAPK1 mRNA stability, thereby influencing DAPK1 expression/function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DAPK1 intronic transcript 1 (non-protein coding) (DAPK1-IT1).